Healthcare

July 14, 2020

1

HD Medical Awarded FDA Clearance For HD Steth

HD Medical, Inc. of Silicon Valley today announces that its flagship product, HD Steth, has received FDA clearance for all three product classification codes of DQD, DQC and DPS for Electronic Stethoscope, Phonocardiograph and Electrocardiograph combined into one device. HD Steth utilizes cutting-edge AI technology to enable clinicians to perform advanced cardiac evaluation at the point-of-care to save time and lives. About HD Steth HD Steth is an intelligent stethoscope that assists clinicians with capturing, recording, replaying and simultaneously visualizing heart sounds and ECG waveforms on a smart device to help detect multiple cardiac abnormalities. Patented visualization and noise cancellation technology gives HD Steth its edge. Subtle heart sounds are difficult or impossible to hear during auscultation. HD Steth delivers unsurpassed sound fidelity enhanced by visualization which allows clinicians to see the heart sounds providing instant cardiac insights. Clinical Studies & International Sales Success “The quality and intensity of heart sounds are......

Continue Reading >

July 14, 2020

2

New Data to Be Presented at the ISTH 2020 Virtual Congress Demonstrating Octapharma’s Commitment to Patients With Bleeding Disorders

Octapharma announced today that new research findings from its haematology portfolio will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress, taking place on 12–14 July 2020.

The NuProtect study (NCT01712438) investigated the immunogenicity, efficacy and safety of Nuwiq® (simoctocog alfa) in 108 previously untreated patients with haemophilia A. The final results of the study showed"...

Continue Reading >

July 12, 2020

3

Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502/NYSE:TAK) today announced that 13 abstracts are being presented from the company’s Hematology portfolio and pipeline at the International Society on Thrombosis and Haemostasis 2020 Virtual Congress (ISTH 2020). Among the data, Takeda spotlighted four abstracts to highlight its commitment to advancing personalized care through pharmacokinetic (PK)-guided prophylaxis in people living with hemophilia or von Willebrand Disease (VWD) – including scientific updates in patients with hemophilia A from the Phase 3 PROPEL and Phase 3b CONTINUATION studies investigating potential benefits of personalized TAK-660 (rurioctocog alfa pegol) prophylaxis. Two population studies into the PK/pharmacodynamic (PD) profiles of recombinant von Willebrand factor (rVWF), which provide data to assist in the optimization of rVWF personalized......

Continue Reading >

July 10, 2020

4

New Evidence Shows Morinaga Milk’s Probiotic Bifidobacterium breve A1 Improves Memory of Older Adults With Cognitive Dysfunction

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT). The new study, published recently in the Journal of Alzheimer’s Disease, has produced breakthrough results uncovering a novel promising probiotic intervention for early dementia prevention. The clinical study conducted by a clinical research organization, Huma R&D Co., Ltd. in Tokyo, Japan, in collaboration with Morinaga Milk Industry Co., Ltd, is the first RCT report to show a profound cognitive enhancement benefit of the probiotic B. breve A1 in subjects with suspected MCI. “Our......

Continue Reading >

July 10, 2020

5

Laboratory Studies Confirm BETADINE® Antiseptic Products’ Effectiveness Against COVID-19 Virus

Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease.

Testing has demonstrated BETADINE’s® strong in-vitro virucidal activity, killing 99.99% of the SARS-CoV-2 virus in 30 seconds. The products subjected to testing were: BETADINE® antiseptic products,"...

Continue Reading >

July 9, 2020

6

Abbot Laboratories faces multimillion-dollar lawsuit over contract compliance with African Covid-19 Test Kits

The Centurion Law Group has been engaged to institute legal action against American multinational health care company Abbott Laboratories for willfully undersupplying African suppliers of COVID-19 test kits. Even when the African parties made orders first, delivery was effected last or not at all.

“Abbott Laboratories should have known better and their handling of orders of COVID-19 test kits have caused serious health and financial damages"...

Continue Reading >

July 9, 2020

7

New Index: A Young Population Has Been Africa’s Best Defense Against COVID-19 Deaths So Far, But Several Regions Are Dangerously Vulnerable

A new index designed to fill a critical information gap and help African governments, health officials, non-governmental organizations, and others respond to the coronavirus pandemic finds that although Africa has not yet been overwhelmed by COVID-19, several regions are showing troubling signs of vulnerability to the social, economic, and health impacts of an outbreak that should not be ignored.

The Africa COVID-19 Community Vulnerability Index"...

Continue Reading >

July 9, 2020

8

New AMR Action Fund Steps in to Save Collapsing Antibiotic Pipeline With Pharmaceutical Industry Investment of US$1 Billion

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund [www.AMRactionfund.com], a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections"...

Continue Reading >

July 8, 2020

9

Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners

Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) and the New York Academy of Sciences announced today the Winners of the third annual Innovators in Science Award for their excellence in and commitment to innovative science that has significantly advanced the field of rare disease research. Each Winner receives a prize of US $200,000. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200708005039/en/ The 2020 Winner of the Senior Scientist Award is Adrian R. Krainer, Ph.D., St. Giles Foundation Professor at Cold Spring Harbor Laboratory. Prof. Krainer is recognized for his outstanding research on the mechanisms and control of RNA splicing, a step in the normal process by which genetic information in DNA is converted into proteins. Prof. Krainer studies splicing defects in patients with spinal muscular......

Continue Reading >

July 7, 2020

10

Dubai achieves another milestone in healthcare with the launch of state-of-the-art cosmetic surgery hospital

NMC Healthcare has officially launched its new CosmeSurge Hospital in Jumeirah. The facility, completed in December of last year, specialises in providing cosmetic surgeries, and is located near the iconic Burj Al Arab. This will be the 17th branch of the CosmeSurge brand of facilities.

The launch coincides with all the significant measures currently undertaken by the Emirate of Dubai towards bringing life back to normalcy, including the issuance of"...

Continue Reading >


Forex News Headline



Forex Market Video